0001209191-13-035485.txt : 20130703 0001209191-13-035485.hdr.sgml : 20130703 20130703164304 ACCESSION NUMBER: 0001209191-13-035485 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130702 FILED AS OF DATE: 20130703 DATE AS OF CHANGE: 20130703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 13953319 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-07-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2013-07-02 4 M 0 105000 33.00 A 249400 D Common Stock 2013-07-02 4 M 0 9800 16.32 A 259200 D Common Stock 2013-07-02 4 M 0 7500 18.93 A 266700 D Common Stock 2013-07-02 4 S 0 13950 78.94 D 252750 D Common Stock 2013-07-02 4 S 0 68985 79.52 D 183765 D Common Stock 2013-07-02 4 S 0 39365 80.58 D 144400 D Common Stock 4770 I 401(k) Common Stock 5568 I Revocable Trust Stock Option 33.00 2013-07-02 4 M 0 105000 0.00 D 2019-10-21 Common Stock 105000 195000 D Stock Option 16.32 2013-07-02 4 M 0 9800 0.00 D 2013-07-14 Common Stock 9800 0 D Stock Option 18.93 2013-07-02 4 M 0 7500 0.00 D 2018-02-06 Common Stock 7500 33000 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $78.94 (range $78.82 to $79.02). Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $79.52 (range $79.03 to $80.02). Open market sales reported on this line occurred at a weighted average price of $80.58 (range $80.04 to $81.02). Fully vested. Omar White, Attorney-In-Fact 2013-07-03